Posted by admin on November 25, 2014 Leave a Comment
Texans for Stem Cell Research (TSCR), proudly announces its participation in the World Stem Cell Summit, 2014 in San Antonio November 25th, 2014 | Texans for Stem Cell Research (TSCR), proudly announces its participation in the World Stem Cell Summit, 2014 in San Antonio, Texas, December 2-5th, 2014. TSCR will co- host a Welcoming Party for the Genetics Policy Institute, the organizer of the Summit, along with the City of San Antonio and the San Antonio Economic Development Foundation. This event will be held at the San Antonio Convention Center LDR Room, 200 E. Market St. The event will be from 7:30-10:30 pm on December 2, 2014. Featured speakers include Dr. Doris Taylor of the
Posted by admin on February 10, 2014 Leave a Comment
February 9, 2014, 7:00 PM|What 60 Minutes Lesley Stahl learned while reporting on the surprising medical differences between males and females Watch 60 Minutes Overtime Recommend on FacebookTell a friend
Posted by admin on January 23, 2014 Leave a Comment
Scientists have known for years that stem cells in male and female sexual organs are regulated differently by their respective hormones. In a surprising discovery, researchers at the Childrens Medical Center Research Institute at UT Southwestern (CRI) and Baylor College of Medicine have found that stem cells in the blood-forming system which is similar in both sexes also are regulated differently by hormones, with estrogen proving to be an especially prolific promoter of stem cell self-renewal. The research, published in Nature, raises several intriguing possibilities for further investigation that might lead to improved treatments for blood cancers and increased safety and effectiveness of chemotherapy. Before the finding, blood-forming stem cells were thought to
Category Blood, Children, Headlines, Pediatric, Stem Cells, Texas, Texas Research Tags Baylor College of Medicine, blood-forming stem cells, Daisuke Nakada, estrogen, Hideyuki Ogur, hildrens Medical Center Research Institute, hormones, Mary McDermott, pediatric genetics, Sean Morrison, stem cells, UT Southwestern Medical Center
Posted by admin on January 7, 2014 Leave a Comment
Bold New Alliance Among Houstons Leading Health Care Providers to Transform Care Delivery in the Region Clinical Services, Research and Education Greatly Enhanced by New Collaborations for CHI, St. Lukes, Baylor College of Medicine and Texas Heart Institute HOUSTON (Jan. 7, 2014) Three of the regions leading medical institutions Baylor College of Medicine, CHI St. Lukes Health and the Texas Heart Institute have significantly expanded and enhanced their long-standing educational, clinical and research affiliations in conjunction with Englewood, Colo.-based Catholic Health Initiatives, which sponsors and operates the newly named CHI St. Lukes Health. Catholic Health Initiatives, one of the nations largest health systems, announced today that CHI St. Lukes has partnered with Baylor
Posted by admin on November 26, 2013 Leave a Comment
The city of San Antonio will invest $200,000 in a biotech startup founded to develop new advances in stem-cell technology. City Council voted Thursday to invest in StemBioSys, Inc. through a grant to the San Antonio Economic Development Corporation. The money will be used for stem-cell research, development and manufacturing. StemBioSys, founded in 2010, holds two patents and has three others pending. The company has four employees and will hire at least two more in the next year. The company was formed by Dr. Xiao-Dong Chen, a professor at University of Texas Health Science Center at San Antonio, and Dr. Steven Davis, a San Antonio dermatologist, using licensed stem-cell technology Chen created at the university.
Posted by admin on November 19, 2013 Leave a Comment
Research with mice may someday help people recovering from heart attacks, scientists say New insight into the hearts ability to repair itself could help scientists develop ways to improve recovery after a heart attack, a new study of mice suggests. Researchers found that a signaling pathway called the Hippo pathway normally blocks heart repair in adult mice. When certain signals were removed, the animals hearts were able to regenerate after being damaged. This was because specialized heart cells called cardiomyocytes were able to multiply much better after the signals were removed, an ability that is normally lost in damaged hearts, according to the researchers from the Baylor College of Medicine and the Texas
Posted by admin on October 16, 2013 Leave a Comment
Daria O Brians Science Club Adventures in Time Not currently available on BBC iPlayer Series 2 Episode 2 of 6 Dara O Briain and the team go on a journey through time to discover what it is and how to get more of it. Watch Video Recommend on FacebookTell a friend
Category Body Parts, For the Kids!, Organs, Stem Cells, Texas, Texas Research, Videos Tags BBC, Daria O Brian's Science Club, Doris Taylor, For the Kids!, Helen Czerski, organs, Texas Heart Institute
Posted by admin on September 13, 2013 Leave a Comment
HOUSTON Gov. Rick Perry today announced a $3 million investment through the Texas Emerging Technology Fund (TETF) to create the Center for Cell and Organ Biotechnology in collaboration with the Texas Heart Institute (THI) and Texas A&M University College of Veterinary Medicine & Biomedical Sciences. This center represents another step toward making Texas the forefront of biotechnology for generations to come, Gov. Perry said. The investment is all a part of the culture of creation weve nurtured in Texas, built upon the concept that if you give bright and visionary people the freedom to innovate and pursue their dreams, good things will happen. I could not be prouder that this life-affirming research will be
Posted by admin on June 20, 2013 Leave a Comment
Its a pioneering procedure. Doctors at Austins Heart Hospital are taking a patients own stem cells from bone marrow a few days after a heart attack and injecting those stem cells back into formerly blocked arteries. Dr. Roger Gammon is an Interventional Cardiologist who leads the research team at the hospital. He says, We think those stem cells in particular are most able to recover heart muscle and grow new blood vessels in an area which could save that heart muscle. This trial could be a critical next step in fighting the nations number one killer. Medication and surgery to open blocked arteries have dramatically improved survival rates for people with heart disease. But once
Category Headlines, Heart Attacks, Heart Disease, Heart Failure, Stem Cells, Texas, Texas Research, Videos Tags Austin's Heart Hospital, Bone Marrow, heart attack, Roger Gammon, stem cells
Posted by admin on June 19, 2013 Leave a Comment
Texas Heart Institute One of Many Hospitals Seeing Success in Organ Creation On average, 18 people die each day awaiting an organ donation one person is added to the waiting list for organ transplants every ten minutes. Although nearly 80 people receive an organ transplant per day according to OrganDonor.gov, the gap between donations made and those awaiting organs is devastating for those on the waiting list. There is good news on the horizon for the 100,000-plus people awaiting a transplant, however. Researchers in Texas and across the globe are working on a way to create organs from the patients own body. While 3D printed versions of large organs such as kidneys are
Category Headlines, Heart Disease, Stem Cells, Technology, Texas, Texas Research, Videos, World News Tags 3D printed, Doris Taylor, OrganDonor.gov, Stanford, stem cells, Texas Heart Institute
Posted by admin on May 30, 2013 Leave a Comment
Doctors at the Texas Heart Institute (THI) at St. Lukes Episcopal Hospital (SLEH) announced that they have performed an investigational procedure on six patients in a new FDA-approved clinical trial to evaluate therapy that uses regenerative cells derived from a patients own adipose (body fat) tissue to treat a severe form of heart failure. The trial, known as ATHENA, marks the first such study in the United States using adipose-derived regenerative cells, known as ADRCs, which are harvested using a technology developed by Cytori Therapeutics, a biotechnology company that specializes in cell therapies. Previous studies in Europe have shown the safety and feasibility of the therapy. We have found that body fat tissue is a
Category Adipose, Headlines, Heart Disease, Heart Failure, Stem Cells, Technology, Texas, Texas Research Tags adipose, ADRC, Cytori Therapeutics, Fat-Derived Regenerative Cells, heart failure, James T. Willerson, Texas Heart Institute
Posted by admin on April 30, 2013 Leave a Comment
Texas Heart Institute not concerned about changes at St. Lukes A spokesman for Texas Heart Institute said the center does not have any ongoing research that would be in direct conflict with the faith-based medical care of Denver-based Catholic Health Initiatives. The St. Lukes Episcopal Health System said April 19 it decided to sell to CHI, the nations second-largest faith-based health system. Shortly after, concerns arose about whether the Catholic provider would eliminate any procedures currently offered at St. Lukes. The Texas Heart Institute is affiliated with but not owned or governed by St. Lukes, though it is housed within St. Lukes Episcopal Hospital in the Texas Medical Center. CHI issued a statement April 26
Category Headlines, Heart Disease, Heart Failure, Stem Cells, Technology, Texas, Texas Research, Vascular Disease, World News Tags Catholic Health Initiatives, CHI, Denton Cooley, St. Luke's Episcopal Hospital, Texas Heart Institute
Posted by admin on April 25, 2013 Leave a Comment
Latest advances in treatment for Alzheimers,traumatic brain injury and stroke to be presented at symposium AUSTIN, Texas (April 24, 2012) Some of the countrys leading practitioners will discuss the cutting-edge treatments and imaging techniques being developed to treat Alzheimers, traumatic brain injury and stroke at a symposium on May 1 in Austin. Collaborating for Cures: Research, Rehabilitation & Treatment for Alzheimers, Brain Injury & Stroke will feature presentations on The Promise of Stem Cells; Current treatment of closed head injury, Disorders of consciousness, Imaging in dementia, Drug screening for degeneration, Pain syndrome after stoke, Emerging therapeutics in ischemic stroke and Neurorecovery vs neurorehabilitation as well as provide a forum for leading scientists in the
Category Alzheimer's, Headlines, Preclinical, Stroke, Texas, Texas Research Tags Alzheimers, brain injury, CORE Health Care, Core Health Foundation, Moss Rehabilitation & Research Institute, Nantz National Alzheimers Center, NeuroTexas Institute, Reliant Austin Rehabilitation Hospital, Seton Brain & Spine Institute, St. Davids HealthCare, Stroke, Texans for Stem Cell Research, Texas Cures Education Foundation, TIRR Memorial Hermann, UT Southwestern
Posted by admin on March 1, 2013 Leave a Comment
Reprogramming Adult Cells to Stem Cells Works Better with One Gene Turned Off The removal of a genetic roadblock could improve the efficiency of converting adult cells into stem cells by 10 to 30 times, report scientists from The Methodist Hospital Research Institute and two other institutions in the latest issue of Cell. The discovery six years ago that scientists can convert adult cells into inducible pluripotent stem cells, or iPSCs, bolstered the dream that a patients own cells might be reprogrammed to make patient-specific iPSCs for regenerative medicine, modeling human diseases in petri dishes, and drug screening, said Rongfu Wang, Ph.D., Principal Investigator and Director of the Center for Inflammation and Epigenetics. But reprogramming
Category Drug Discovery, Headlines, Regenerative Medicine, Stem Cells, Texas, Texas Research Tags Center for Inflammation and Epigenetics, drug screening, epigenetic, inducible pluripotent stem cells, Regenerative Medicine, Rongfu Wang, The Methodist Hospital Research Institute
Posted by admin on February 22, 2013 Leave a Comment
A University of Texas spinoff company has pulled in $2 million to test a new technique for culturing non-embryonic stem cells. According to a regulatory filing, StemBioSys raised at least $2 million of a $3.5 million equity offering. A company representative was not available to elaborate, but CEO Dr. Steven Davis told the San Antonio Business Journal last year when the company began raising the round that it would fund research projects to validate the quality of the stem cells generated by the companys technology. StemBioSys is developing XC-marrow ECM, a propriety three-dimensional culture for growing mesenchymal stem cells from bone marrow, adipose tissue and umbilical cord blood. These immature cells have multiple potential uses
Posted by admin on February 7, 2013 Leave a Comment
Every week, it seems, theres a new breakthrough in 3-D printing that promises us the ability to (eventually) fabricate some new thing in one of those glass-walled wonder boxes. Such things have included everything from spare parts for the International Space Station above to the beef on our dinner plates to the organs inside our bodies. Although this last idea of fabricating body parts may seem the most fanciful, a team of scientists is reporting a breakthrough in 3-D printing using human embryonic stem cells that could purportedly lead to life-like bioengineered tissue and, eventually, artificial organs tailor-made for specific patients. Researchers have been able to engineer tissue samples in then past by combining artificial
Posted by admin on January 27, 2013 Leave a Comment
Doris Taylor and her team are building new organs, hoping to reverse disease, maybe even the aging process By Maggie Galehouse | January 23, 2013 It sounds like science fiction, but it is isnt. On the ninth floor of the Texas Heart Institutes Denton Cooley building, Doris Taylor and her team are building human hearts, with help from pigs and stem cells. We think a pig heart is a perfect scaffold for a human heart, based on its structure and size, says Taylor, a passionate scientist with a Ph.D. in pharmacology. One recent morning, a pig heart hung suspended in a clear homemade tank in the lab built for Taylor and her team. Filled with
Category Headlines, Heart Disease, Heart Failure, Regenerative Medicine, Stem Cells, Texas, Texas Research Tags Doris Taylor, Houston Chronicle, Jame T. Willerson, Maggie Galehouse, Regenerative Medicine, stem cells, Texas Heart Insitute
Posted by admin on January 21, 2013 Leave a Comment
After a nationwide competition, Texas Heart Institute at St. Lukes Episcopal Hospital has been chosen as the Biorepository Core Lab for the National Heart, Lung and Blood Institutes network of cardiac stem cell research centers. The seven centers, collectively known as the Cardiovascular Cell Therapy Research Network, are home to a network of physicians, scientists and support staff who work together to study stem-cell therapy for treating heart disease. The goals of the network are to complete research studies that will potentially lead to more effective treatments for patients with cardiovascular disease, and to share knowledge quickly with the health care community. Read Full Story Recommend on FacebookTell a friend
Posted by admin on January 8, 2013 Leave a Comment
Scar Tissue In Damaged Hearts Reprogrammed By Gene Therapy Into Healthy Heart Muscle A cocktail of three specific genes can reprogram cells in the scars caused by heart attacks into functioning muscle cells, and the addition of a gene that stimulates the growth of blood vessels enhances that effect, said researchers from Weill Cornell Medical College, Baylor College of Medicine and Stony Brook University Medical Center in a report that appears online in the Journal of the American Heart Association. The idea of reprogramming scar tissue in the heart into functioning heart muscle was exciting, said Dr. Todd K. Rosengart, chair of the Michael E. DeBakey Department of Surgery at BCM and the reports corresponding
Posted by admin on January 4, 2013 Leave a Comment
The Alliance for Regenerative Medicine (ARM), the international organization representing the interests of the regenerative medicine community, today announced that 18 ARM members will be presenting at the Biotech Showcase 2013 meeting in San Francisco next week. Featuring company presentations by leading organizations in the industry, Biotech Showcase, produced by EBD Group and Demy-Colton Life Science Advisors, has emerged as a high profile forum for mid-, small- and micro-cap and private companies seeking access to the investor community and potential collaborators. Collectively, the ARM members presenting will showcase the wide scope of progress that is taking place in the regenerative medicine and cell therapy field. (Press Release) Recommend on FacebookTell a friend
See the article here:
Texas Research : Stem Cell Cite
- Stem Cell Science and Human Research Studies Ahead of Cargo Arrival - NASA Blogs - February 21st, 2024
- Harvard Stem Cell Institute (HSCI) - December 29th, 2023
- Stem cell - Wikipedia - December 29th, 2023
- A Look Inside Stem Cells Helps Create Personalized Regenerative ... - May 17th, 2023
- Heart disease study shows hope for stem cell treatment - March 4th, 2023
- Focus On Stem Cell Research | National Institute of Neurological ... - March 4th, 2023
- Stem Cell Research: Argumentative Essay - Free Essay Example - Edubirdie - March 4th, 2023
- Automated Cell Culture Systems Market Size to Hit USD 12.43 Billion by 2033; Growing Stem Cell Research & Development and Increasing Prevalence of... - October 21st, 2022
- NIH Guidelines for Human Stem Cell Research - October 13th, 2022
- Ethics of Stem Cell Research - Blue Marble Space Institute of Science - October 13th, 2022
- Global Cell Therapy Market Report (2022 to 2028) - Featuring Thermo Fisher Scientific, MaxCyte, Danaher and Avantor Among Others -... - October 13th, 2022
- Stem Cell Therapy Market (2022-2029) Size Will Escalate Rapidly in the Near Future: Osiris Therapeutics, Molmed - Digital Journal - October 13th, 2022
- Fighting One Disease or Condition per Day - Daily Kos - October 13th, 2022
- The Issue of Tissue: Getting to the Source of the HIV Reservoir - amfAR, The Foundation for AIDS Research - October 13th, 2022
- Cell Isolation Global Market Report 2022: Significant Growth in the Medical and Pharmaceutical Industries Driving Sector - ResearchAndMarkets.com -... - October 13th, 2022
- Nancy and Geoffrey Stack Family Foundation give $2 million to UCI Health - UCI News - October 4th, 2022
- Cell Isolation Market is expected to generate a revenue of USD 20.50 Billion by 2028, Globally, at 15.70% CAGR: Verified Market Research -... - September 25th, 2022
- Creating stem cells from minipigs offers promise for improved treatments - University of Wisconsin-Madison - September 16th, 2022
- Hemostemix Announces the Appointment of Dr. Renzo Cecere, MD, FRCSC to Its Scientific Advisory Board - Yahoo Finance - September 16th, 2022
- Genomics study identifies unique set of proteins that restores hearing in zebrafish - National Institutes of Health (.gov) - September 16th, 2022
- Discovered Key Mechanisms to Improve Intestinal Regeneration and Alleviate the Side Effects of Radiotherapy - Imaging Technology News - September 16th, 2022
- Global Cell Expansion Market Size to Grow at a CAGR of 15% during the Forecast Period 2022-2027 - Digital Journal - September 16th, 2022
- The American Cancer Society Awards $2.1 Million to Montefiore Einstein Cancer Center to Support Cancer Research and Tackle Inequities - Yahoo Finance - September 16th, 2022
- Hair Restoration Market | Stem Cell hair Restoration and Low-level Laser Therapy (LLLT) segment are Expected to Witness Significant CAGR - MDC... - August 30th, 2022
- Stem Cell Therapy for Parkinson's: Current Developments - Healthline - August 5th, 2022
- 'Off the shelf' CAR T cells for cancer treatment? - Boston Children's Answers - Boston Children's Discoveries - August 5th, 2022
- Inflammation accelerates aging of the hematopoietic system - EurekAlert - August 5th, 2022
- New patent-pending method mass-produces antitumor cells to treat blood diseases and cancer - Purdue University - August 5th, 2022
- Cell Therapy Technologies Market worth $8.0 billion by 2027 - Exclusive Report by MarketsandMarkets - PR Newswire - August 5th, 2022
- Twenty-Five Years After My House Call To Dolly: What Have We Learned About Cloning And How Did We Learn It? - Forbes - August 5th, 2022
- Tendon Stem Cell Therapy Market is Booming Worldwide with Strong Growth Prospects | Cellualar Dynamics, Cellectis, International Stem cell... - July 27th, 2022
- [Pangyo Bio & Medical] Theragen Bio discovers MAST4 Protein that Regulates Bone Cartilage Development For 'The First Time in The World' - Digital... - July 27th, 2022
- Cell Culture Media Market Size Worth $10.2 Billion by 2030: Grand View Research, Inc. - PR Newswire - July 27th, 2022
- Cryopreservation Equipment Market Report 2022-2028: Importance of Cryopreservation for Success of Cell-Based Therapies Presents Opportunities -... - July 27th, 2022
- Whitmer axes stem cell research, pregnancy center funding over abortion access concerns - MLive.com - July 19th, 2022
- Stem Cell - National Human Genome Research Institute Home - July 11th, 2022
- Induced Pluripotent Stem Cells (iPS) | UCLA Broad Stem Cell Center - July 11th, 2022
- Global 3D Cell Culture Market To Be Driven By Growing Impact Of Economy On Regenerative Medicine, Emerging Applications Of Gene Therapy During The... - July 11th, 2022
- New Combination Therapy Effective in Pediatric Leukemia - Technology Networks - June 22nd, 2022
- MIT Pioneers Technology To Grow Customizable Wood Products in the Lab With Little Waste - SciTechDaily - June 22nd, 2022
- First-of-its-Kind Stem Cell and Gene Therapy Highlighted at Annual Stem Cell Meeting - Newswise - June 13th, 2022
- Scientists hope this injectable stem cell gel can repair heart attack damage and avoid transplants - Euronews - June 13th, 2022
- Axol Bioscience Introduces CiPA-Validated Human Stem Cell-Derived Ventricular Cardiomyocytes to Help Improve Drug Discovery - Business Wire - June 13th, 2022
- Fasting has pros and cons for muscle repair in mice - Futurity: Research News - June 13th, 2022
- First Clinical Trial of Transplanted 3D Ear Using Human Cells Proves Successful via 3DBio Therapeutics - Tech Times - June 4th, 2022
- Insights on the Dimethyl Sulfoxide (DMSO) Global Market to 2027 - Expanding Research and Development in Stem Cell Transplantation to Benefit Demand... - May 15th, 2022
- Scientists Rejuvenate Skin Cells by 30 Years, with Pioneering Potential - BioSpace - May 15th, 2022
- Global Flow Cytometry Market is expected to grow at a lucrative rate of 8% to reach $11 billion by 2026 A Robust Tool that Defines New Era for... - May 15th, 2022
- Global Mesenchymal Stem Cells Market Research Report to 2027 - Featuring Astellas Pharma, Axol Biosciences and BrainStorm Cell Therapeutics Among... - May 2nd, 2022
- Researchers share insights about the mechanisms of human embryo and create method to develop transcriptionally similar cells in tissue culture -... - May 2nd, 2022
- Flow Cytometry Market is Estimated Drive the Industry Growth Across World in Coming Year 2030 Queen Anne and Mangolia News - Queen Anne and Mangolia... - May 2nd, 2022
- Mini-heart chamber beats on its own just like the real thing - Futurity: Research News - May 2nd, 2022
- The Case Against Embryonic Stem Cell Research: An ... - April 6th, 2022
- Burst of accumulated zinc shows how the mineral boosts immune function, suggesting ways to improve health - EurekAlert - April 6th, 2022
- Hoyer Statement on the Retirement of Congressman Fred Upton - Majority Leader - April 6th, 2022
- 11 Stem Cell Research Pros and Cons Vittana.org - March 25th, 2022
- Research Associate, Cancer and Stem Cell Laboratory job with UNIVERSITY OF SYDNEY | 287031 - Times Higher Education - March 25th, 2022
- Google still has a problem with stem cell and unproven therapies - STAT - STAT - March 25th, 2022
- Medeze Named Frost & Sullivan's 2021 Company of the Year in the Southeast Asia Stem Cell Banking Industry - PR Newswire - March 25th, 2022
- Bone Marrow-Derived Stem Cells (BMSCS) Market Report- Growth in Future with Size, Share, Growth, and Key Companies Analysis Cord Blood Registry... - March 25th, 2022
- Autologous Stem Cell and Non-Stem Cell Based Therapies Market Future Business Opportunities 2022-2028 | Caladrius Biosciences, Vericel Corporation,... - March 25th, 2022
- Cell Therapy Market Trends, Revenue, Key Players, Growth, Share and Forecast Till 2028 Reports and Data - Digital Journal - March 25th, 2022
- This Fancy AF Face Cream Was Invented by a Stem Cell Researcher - VICE - March 25th, 2022
- Freeze Thaw Chambers Market: The cryopreserved products segment is expected to drive the growth of the market - BioSpace - January 5th, 2022
- As Nave as They Get - Weizmann Wonder Wander - News, Features and Discoveries - Weizmann Institute of Science - January 5th, 2022
- Jake's mice: Searching for answers to the puzzle of autism - huntingdondailynews.com - January 5th, 2022
- Primary Cells, Stem Cells, Culture Media and Reagents Market to Witness Rapid Growth by 2029 | BrainStorm Cell Therapeutics Inc., Caladrius... - January 5th, 2022
- Gait Rehabilitation System Market: Rising incidence of various neurological disorders to drive the market - BioSpace - January 5th, 2022
- ARVO Foundation Announces 2022 Bert M. Glaser, MD Award for Innovative Retina Research Recipient - Newswise - January 5th, 2022
- Communication between cells plays a major role in deciding their fate - EurekAlert - December 24th, 2021
- The 10 Most Compelling Research Stories of 2021 - BioSpace - December 24th, 2021
- MRC Lead Apologizes Following Bullying Allegations - The Scientist - December 24th, 2021
- California Proposition 14, Stem Cell Research Institute ... - November 22nd, 2021
- Ethical Issues in Stem Cell Research - PubMed Central (PMC) - November 22nd, 2021
- Opinion | How Covid Raised the Stakes of the War Between Faith and Science - The New York Times - November 8th, 2021
- What is Stem Cell Research? | The Benefits of Stem Cell Research - October 5th, 2021
- An Overview of Stem Cell Research | The Center for Bioethics ... - October 5th, 2021
- Stem Cell Research: Uses, Types & Examples - October 5th, 2021
- Stem Cells | National Institutes of Health (NIH) - October 5th, 2021
- Stem cells: Therapy, controversy, and research - October 5th, 2021